- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03032861
The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?
25. april 2017 opdateret af: Thais Cesar, São Paulo State University
Influence of the Prebiotic Effect of Orange Juice on the Bioavailability of Flavanones After Chronic Intake of Orange Juice.
This study aimed investigate the chronic effect of orange juice consumption on gut microbiota and in the bioavailability of flavanones and metabolites by feces, blood and urine analysis.
Studieoversigt
Detaljeret beskrivelse
Non-randomized study with interrupted time series and open-label, in which women were enrolled and advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages during 30 days before of intervention (n=10; BMI 23.8 kg/m2; 28 years).
After 30 days, the participants will consume during 60 days 300 mL of orange juice daily.
After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout.
Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and in the bioavailability of its flavanones.
The recruitment process began in September 2016 and the intervention was carried out from October 2016 to February 2017, and the data analysis will start in February 2017.
The sample number took into account variances on blood hesperitin levels with a type I error α = 0.05 and a type II error β = 0.2 (80% power) (Silveira et al., 2015).
The minimum sample size should have six individuals into the same group.
Considering an approximately 15% dropout rate, the final sample size of study was constituted by 10 women.
Primary endpoint is the changes in total bacteria population (Lactobacillus spp., Bifidobacterium spp., and reduction of Clostridium spp.) that can result in increased of butyric, acetic, and propionic acid concentrations, and reduction of ammonium production.
Secondary endpoint is enhancement of bioavailability of flavanones (hesperitin, naringenin) and metabolites in the blood, urine and feces.
Kolmogorov Smirnov and Levene test will be used to assess the normality and homogeneity of data, respectively.
One-way analysis of variance (ANOVA) will be apply to determine the intervention effect over the time 0, 30 day, 60 day, 90 day, and 120 day).
P significance was set up ≤ 0.05.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
10
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Sao Paulo
-
Araraquara, Sao Paulo, Brasilien, 14800-903
- Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 55 år (Voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Kvinde
Beskrivelse
Inclusion Criteria:
Healthy women BMI 18.5 - 29.9 kg/m2.
Exclusion Criteria:
Gastrointestinal diseases Pregnant women Regular use of medications Dietary restrictions, vegetarian diet, macrobiotic, etc. Use of vitamins or dietary supplements Use of probiotics or prebiotics in the last 3 months and antibiotics in the last 6 months.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Orange juice
Ten women will consume 100% orange juice (300 mL/day) during 60 days.
|
Thirty days before the beginning of trial, women (n= 10; BMI 23.8 kg/m2; 28 years) will be advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages.
After 30 days, the participants will consume 300 mL of orange juice daily during 60 days.
After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout.
Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and the bioavailability of its flavanones in blood, urine and feces.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Total counting of aerobic bacteria and facultative anaerobic bacteria
Tidsramme: 4 months
|
4 months
|
|
Determination of butyric acid
Tidsramme: 4 months
|
4 months
|
|
Determination of acetic acid
Tidsramme: 4 months
|
4 months
|
|
Ammonium concentration
Tidsramme: 4 mounths
|
4 mounths
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Bioavailability of hesperitin and naringenin in the blood, urine and feces
Tidsramme: 4 months
|
Quantification of hesperidin and naringenin and identification and quantification of their metabolites in the blood, urine and feces
|
4 months
|
|
Body mass index
Tidsramme: 4 months
|
4 months
|
|
|
Body lean mass
Tidsramme: 4 months
|
4 months
|
|
|
Body fat mass
Tidsramme: 4 months
|
4 months
|
|
|
% body fat
Tidsramme: 4 months
|
4 months
|
|
|
Ratio waist/hip
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Glucose
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Insulin
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Total cholesterol
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Low density lipoprotein cholesterol
Tidsramme: 4 mounths
|
4 mounths
|
|
|
High density lipoprotein cholesterol
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Triglycerides
Tidsramme: 4 mounths
|
4 mounths
|
|
|
hsCRP
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Alkaline phosphatase
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Aspartate enzyme aminotransferase
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Alanine enzyme aminotransferase
Tidsramme: 4 mounths
|
4 mounths
|
|
|
GammaGT
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Glycemic curve
Tidsramme: 4 mounths
|
4 mounths
|
|
|
Insulin curve
Tidsramme: 4 mounths
|
4 mounths
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Thais B Cesar, PhD, São Paulo State University
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
- Silveira JQ, Cesar TB, Manthey JA, Baldwin EA, Bai J, Raithore S. Pharmacokinetics of flavanone glycosides after ingestion of single doses of fresh-squeezed orange juice versus commercially processed orange juice in healthy humans. J Agric Food Chem. 2014 Dec 31;62(52):12576-84. doi: 10.1021/jf5038163. Epub 2014 Dec 15.
- Kanaze FI, Bounartzi MI, Georgarakis M, Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr. 2007 Apr;61(4):472-7. doi: 10.1038/sj.ejcn.1602543. Epub 2006 Oct 18.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. september 2016
Primær færdiggørelse (Faktiske)
1. oktober 2016
Studieafslutning (Faktiske)
1. februar 2017
Datoer for studieregistrering
Først indsendt
6. januar 2017
Først indsendt, der opfyldte QC-kriterier
24. januar 2017
Først opslået (Skøn)
26. januar 2017
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
26. april 2017
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
25. april 2017
Sidst verificeret
1. april 2017
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- SaoPSU2
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
UBESLUTET
IPD-planbeskrivelse
There is still no decision regarding if the individual participant data (IPD) will be available to other researchers.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .